Advances in scientific breakthroughs, such as single-cell technologies, have led to the increased ability to detect diseases. Accurate and early detection of disease can lead to the enhanced effectiveness of treatments and reduce burdens on the healthcare system. Join Partner Justin Briggs and Research Fellow Ted Ling Hu as they do a deep dive into the emerging trends in the field of diagnostics with our panel of experts.
Panelists
- Swamy Vijayan, CEO & Co-founder of Zafrens — Vijayan is a serial entrepreneur who founded Omniome and Plexium. Swamy’s current venture, Zafrens, unlocks cellular analysis through ultra-high throughput single-cell screening. The technique provides deep insights that unlock unprecedented diagnostic and therapeutic value.
- Daniel Georgiev, CEO and Co-founder of Sampling Human — Daniel is the co-founder and CEO of Sampling Human, which creates new technologies that harness the processing power of biology to measure single cells at scale. He is also a tenured professor at the Faculty of Applied Sciences at the University of West Bohemia.
- John McDevitt, Chief Scientist & Founder of OraLiva — McDevitt is the Scientific Founder of Oraliva, Inc. and is a pioneer in the development of programmable bio-nano-chip technologies. He is a Full Professor in the Department of Biomaterials at NYU Dentistry and a member of NYU’s Bioengineering Institute. He also holds a joint appointment at the Tandon School of Engineering (Department of Chemical and Biomolecular Engineering).
